earnings
confidence high
sentiment positive
materiality 0.50
Tempus AI Q2 rev $315M (+90% YoY); raises FY25 guidance to $1.26B, adj EBITDA $5M
Tempus AI, Inc.
2025-Q2 EPS
reported -$0.64
vs consensus -$0.24
▼ miss
(-161.3%)
- Revenue $314.6M (+89.6% YoY); genomics up 115% to $241.8M; data/services +35.7% to $72.8M.
- Gross profit $195.0M (+158% YoY); net loss improved to ($42.8M) from ($552.2M); adj EBITDA ($5.6M) vs ($31.2M).
- Issued $750M 0.75% convertible notes; cash $293M; FY guidance raised: rev ~$1.26B, adj EBITDA $5M.
- Oncology testing volume +26% YoY; hereditary +32%; >212,000 NGS tests delivered in Q2.